Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» July 2012
July 2012
4 Reasons To Buy AcelRx Pharmaceuticals
4 Reasons To Buy AcelRx Pharmaceuticals
Seeking Alpha
AcelRx
Pfizer Earnings Preview: A Pharma Giant Descends From Growth To Value Status
Pfizer Earnings Preview: A Pharma Giant Descends From Growth To Value Status
Seeking Alpha
earnings
Pfizer
Acura Pharma's Earnings Rescheduled For Monday's Close, With Tuesday Conference Call
Acura Pharma's Earnings Rescheduled For Monday's Close, With Tuesday Conference Call
Seeking Alpha
Acura Pharmaceuticals
earnings
Investment Insider: Pharmaceutical industry's best years lie ahead
Investment Insider: Pharmaceutical industry's best years lie ahead
Independent, UK
Major Insider Buying And Diversified Pipeline Has Me Interested In This Speculative Drug Stock
Major Insider Buying And Diversified Pipeline Has Me Interested In This Speculative Drug Stock
Seeking Alpha
Furiex Pharmaceuticals
Lupin looks to acquire brands in the US; eyes 20% growth
Lupin looks to acquire brands in the US; eyes 20% growth
Economic Times, India
Lupin
Angiotech Pharmaceuticals, Inc. Amends Exchange Offer and Consent Solicitation for its Senior Floating Rate Notes Due 2013
Angiotech Pharmaceuticals, Inc. Amends Exchange Offer and Consent Solicitation for its Senior Floating Rate Notes Due 2013
Sacramento Bee, CA
Angiotech
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
NASDAQ
Furiex Pharmaceuticals
Takeda
alogliptin
diabetes
type 2 diabetes
Pfizer Terminates License Agreement With Acura For 3 Development Stage Products
Pfizer Terminates License Agreement With Acura For 3 Development Stage Products
RTT News
Aversion Technology
Biotechs In Motion As New Drug Pipeline Brims
Biotechs In Motion As New Drug Pipeline Brims
investors.com
Amgen
Celgene
Biogen Idec
Gilead Sciences
Regeneron
Vertex Pharmaceuticals
Alexion
Arena Pharmaceuticals
ONYX Pharmaceuticals
United Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »